VHL, BHD and HLRCC Research

VHL UK/Ireland aims to raise funds for key research into the disease and similar genetic conditions.

This page introduces the key researchers who are candidates to receive funding from the VHL UK/Ireland charity raised by donations and fundraising activities. It is not always realised that research into our conditions can have far-reaching benefit into the wider community. A good example is understanding cell metabolism pathways.

At the moment all research activity into the genetic conditions supported by us is conducted in mainland UK. However if you are aware of any other suitable research activity please email us.

Eamonn R. Maher

M.D., FRCP, FMedSci, Professor of Medical Genetics and Genomic Medicine, University of Cambridge, UKResearch is conducted into VHL, HLRCC and BHD.

Eamonn R. MaherRead Eammon’s Cambridge profle
Watch an interview with Eamonn

BA MA Ph.D. Camb, BM Brist, BM BCh Oxf, Professor of Molecular and Population Genetics, Nuffield Department of Medicine Oxford, UK

The identification of Fumarate Hydratase (FH) gene being responsible for HLRCC is widely referenced in Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer (Tomlinson IP et al., 2002 )

Ian TomlinsonRead Ian’s profile
Find out about the work of his group.

BSc., MSc., Ph.D., Research Group Leader, Beatson Institute of Cancer Research, Glasgow, Scotland, UK

Eyal GottliebRead Eyal’s profile
Find out more about the work of his laboratory

VHL UK/Ireland aims to raise funds via fundraising and donations for research, provide information and support for those affected and raise awareness.

Find out more →

Copyright © 2013 - 2019

VHL UK/Ireland is a registered charity in England and Wales 1160381 and Ireland 2010139

Charity Trust No: CT54346